Understanding Thyroid Levels: TSH, fT3 & fT4 Explained

Understanding Thyroid Values: TSH, fT3 and fT4

Thyroid abnormalities are common in Germany and can remain unnoticed for long periods of time. The small gland in the neck influences energy metabolism, heart rate, body temperature and many other bodily functions. Fatigue, changes in weight, palpitations or concentration problems can be signs of thyroid dysfunction – although these symptoms are non-specific and can have many other causes.

A blood test can provide important information. Yet laboratory results often raise new questions: terms such as TSH, fT3 and fT4 sound technical, and reference ranges can differ between laboratories. It is therefore important to interpret these values together with symptoms, medical history, medication use and other findings.

This article explains what your thyroid values mean, how TSH, fT3 and fT4 interact, and why a closer look at this system can matter for long-term health.

What does the thyroid do – and why is it relevant to longevity?

The thyroid is a butterfly-shaped gland located below the larynx and weighs around 20 grams in adults. Its hormones influence numerous tissues and organ systems.

They regulate, among other things:

• Energy metabolism: how much energy the body uses
• Body temperature
• The cardiovascular system: including heart rate and vascular function
• Cognitive functions and mood
• Growth, development and numerous metabolic processes

When the thyroid is significantly underactive, many bodily processes slow down. In pronounced hyperthyroidism, heart rate and metabolic activity increase; over time, risks such as atrial fibrillation or bone loss can rise.

Subclinical thyroid dysfunction can also be clinically relevant. However, the risk depends heavily on whether hypothyroidism or hyperthyroidism is present, how strongly TSH is altered, the person's age and existing comorbidities. Health risks become particularly relevant in people with markedly suppressed TSH or more pronounced elevations in TSH.

TSH: Why it is the most important thyroid marker in a blood test

When a doctor assesses thyroid function, TSH is usually the first marker measured. There is a clear reason for this.

TSH stands for thyroid-stimulating hormone. It is not produced by the thyroid itself, but by the pituitary gland. It is one of the central regulatory signals controlling thyroid activity.

The feedback loop works, in simplified terms, in four steps:

1. Regulation: The hypothalamus and pituitary gland respond to circulating thyroid hormone concentrations.
2. Signal: If thyroid hormone levels are too low, the pituitary gland generally increases TSH secretion.
3. Response: TSH stimulates the thyroid to produce thyroid hormones.
4. Feedback: As T3 and T4 rise, TRH and TSH secretion is reduced through negative feedback.

TSH therefore indicates how strongly the pituitary gland is stimulating the thyroid.

• Elevated TSH: Can indicate primary hypothyroidism. The pituitary increases stimulation because the thyroid is not producing enough hormone.
• Low TSH: Can indicate hyperthyroidism, for example due to Graves' disease or autonomously functioning thyroid tissue. Medication and other factors can also affect TSH.

The laboratory reference range for TSH in younger adults is often approximately 0.4 to 4.0 mU/L. Age-related differences, pregnancy and laboratory-specific reference ranges need to be considered. The actual laboratory report and clinical context are therefore what matter.

TSH is the most important starting marker when assessing primary thyroid dysfunction. If results are abnormal, or if specific clinical questions arise, additional thyroid hormones may be measured.

Free T4 (fT4): The most important thyroid hormone alongside TSH

The thyroid primarily produces thyroxine, or T4. Most T4 circulates in the blood bound to transport proteins. The unbound fraction is called free T4, or fT4, and is available to tissues.

Some T4 is converted into T3 throughout the body by enzymes known as deiodinases. Assessing TSH and fT4 together therefore provides a considerably more precise picture of thyroid function than TSH alone.

Depending on the laboratory and analytical method, the reference range for fT4 is often approximately 12 to 22 pmol/L. The range stated on the individual laboratory report is what matters.

Typical patterns include:

• High TSH + low fT4: classic pattern of overt primary hypothyroidism.
• High TSH + normal fT4: pattern of subclinical hypothyroidism.
• Low TSH + high fT4: indication of overt hyperthyroidism.
• Low TSH + normal fT4: may occur in subclinical hyperthyroidism; in this situation, measuring T3 or fT3 can provide additional information.

Free T3 (fT3): The biologically active thyroid hormone

Triiodothyronine, or T3, is a particularly biologically active thyroid hormone. A large proportion of circulating T3 is produced outside the thyroid through the conversion of T4 in tissues including the liver, kidneys and others. This process is regulated by enzymes called deiodinases.

Depending on the laboratory and testing method, the reference range for fT3 is often approximately 3.1 to 6.8 pmol/L.

For the diagnosis of classical primary hypothyroidism, TSH and fT4 remain the main parameters. However, T3 or fT3 can provide additional information, particularly when TSH is suppressed, when hyperthyroidism is suspected, or in selected clinical situations.

In some forms of hyperthyroidism, for example, T3 may already be elevated while fT4 is still within the reference range. Measuring T3 can help identify such patterns.

Conversely, a low fT3 result with normal TSH and fT4 should not automatically be interpreted as "hidden hypothyroidism." T3 levels can change during acute or chronic illness, severe calorie restriction and other metabolic stressors. This so-called non-thyroidal illness or low-T3 pattern needs to be distinguished from primary thyroid disease.

At YEARS, we measure TSH, fT4 and fT3 together. This gives the physician a broader hormonal profile to interpret. The key point is medical interpretation within the individual clinical context; one isolated value does not constitute a diagnosis.

There is also reverse T3, or rT3, a biologically inactive metabolite of T4. Its concentration can change during severe illness, among other situations. Measuring rT3 has no established routine benefit when diagnosing hypothyroidism in otherwise stable patients and is not part of the standard YEARS panel.

How TSH, fT3 and fT4 work together

These markers are part of the hypothalamic-pituitary-thyroid axis, or HPT axis.

In simplified terms, the hypothalamus releases TRH. The pituitary gland responds by releasing TSH. TSH stimulates the thyroid to produce T4 and T3. T4 is additionally converted into T3 in various tissues. T3 and T4 then provide negative feedback to the hypothalamus and pituitary gland.

For the assessment of primary hypothyroidism, TSH and fT4 form the diagnostic basis. fT3 can add information depending on the findings and the clinical question. When all three values are measured, they need to be interpreted together with symptoms, medication, comorbidities and other examination findings.

Important factors that can affect thyroid values

Thyroid values show biological variation. TSH, for example, follows a pronounced circadian rhythm. Acute illness, pregnancy and various medications can affect results.

Higher doses of biotin are also relevant: biotin can directly interfere with certain laboratory assays and can lead to apparently low TSH and apparently high thyroid hormone values.

Medications such as lithium, by contrast, can alter thyroid function itself. A single laboratory value taken out of context therefore does not provide a complete assessment.

Recognising hypothyroidism: Values, symptoms and grey areas

Hypothyroidism is one of the most common endocrine disorders. Two forms are especially relevant clinically:

1. Overt hypothyroidism: TSH is elevated and fT4 is low. In primary overt hypothyroidism, thyroid hormone replacement is generally indicated.
2. Subclinical hypothyroidism: TSH is elevated while fT4 remains within the reference range.

Subclinical hypothyroidism is a clinical grey area. Whether treatment is appropriate depends on several factors, including the degree and persistence of TSH elevation, age, symptoms, pregnancy or plans for pregnancy, antibody status and other risk factors. A mildly elevated TSH does not automatically mean that treatment is necessary.

Possible symptoms of hypothyroidism include:

• Persistent fatigue and exhaustion
• Sensitivity to cold
• Weight gain
• Dry skin and hair loss
• Problems with concentration
• Low mood and reduced drive
• Constipation
• Slow heart rate

These symptoms are non-specific and can have many other causes.

In regions with adequate iodine intake, Hashimoto's thyroiditis is a common cause of primary hypothyroidism. In this autoimmune condition, the immune system targets components of the thyroid. Detecting antibodies such as TPO antibodies can support the diagnosis of autoimmune thyroiditis; antibody status, thyroid function and structural findings need to be interpreted together.

TPO antibodies and thyroglobulin antibodies are not included in the YEARS Core® programme. If there is clinical suspicion, they can be tested separately.

A high-resolution thyroid ultrasound is also part of the YEARS check-up. It can detect structural changes, nodules or an ultrasound pattern compatible with autoimmune thyroiditis. Thyroid ultrasound is not mandatory for every isolated laboratory abnormality, but as part of a comprehensive assessment it can provide additional structural information.

Recognising hyperthyroidism: When the thyroid is overactive

Hyperthyroidism is less common than hypothyroidism but can have clinically relevant consequences if left untreated.

• Overt hyperthyroidism: TSH is suppressed and fT3 and/or fT4 are elevated.
• Subclinical hyperthyroidism: TSH is low while fT3 and fT4 remain within the reference range.

Typical symptoms include:

• Palpitations and an elevated heart rate
• Restlessness, nervousness and irritability
• Sleep problems
• Weight loss despite a normal or increased appetite
• Excessive sweating and heat intolerance
• Tremor
• More frequent bowel movements or diarrhoea

Common causes include Graves' disease and thyroid autonomy, where parts of the thyroid produce hormones independently of normal regulation.

Untreated overt hyperthyroidism increases the risk of atrial fibrillation and can accelerate bone loss. Persistent subclinical hyperthyroidism is also associated with increased cardiovascular risk, particularly when TSH is markedly suppressed and in older adults.

Laboratory testing provides the basis for diagnosis. Depending on the findings, ultrasound, antibody testing or additional examinations may be useful. Thyroid ultrasound is included as standard in the YEARS Core® programme.

One isolated value is not a diagnosis

TSH is the most important starting marker when assessing primary thyroid dysfunction. fT4 complements the assessment by showing how much unbound T4 is circulating in the blood. fT3 can provide additional information, particularly in certain hyperthyroid patterns and selected clinical situations.

At YEARS, we routinely measure TSH, fT3 and fT4 as part of our laboratory panel. This allows the treating physician to interpret the three values together. We also perform thyroid ultrasound and assess all findings within the context of the broader examination.

The key principle remains the same: laboratory results should never be treated in isolation. Symptoms, medical history, medication, physical examination and structural findings all contribute to appropriate medical interpretation.

→ Book a consultation at YEARS → Learn more about the YEARS Core® programme

This article is intended for general information only and does not replace individual medical advice. Diagnosis and treatment decisions regarding thyroid disease should always be made by a physician.

Sources

• Auer, J., Scheibner, P., Mische, T., Lang, T., Eber, B., & Puschmann, R. (2001). Subclinical hyperthyroidism as a risk factor for atrial fibrillation. American Heart Journal, 142(5), 838–842.
• Chaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017). Hypothyroidism. The Lancet, 390(10101), 1550–1562.
• DEGAM. (2023). S2k Guideline: Elevated TSH in Primary Care. AWMF Registration No. 053-046.
• Forum Schilddrüse e.V. (2021). Die Schilddrüse – medizinisches Wissen und praktische Tipps.
• Selmer, C., Olesen, J. B., Hansen, M. L., et al. (2014). Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. The Journal of Clinical Endocrinology & Metabolism, 99(7), 2372–2382.
• Van Uytfanghe, K., et al. (2023). Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status. Thyroid.